S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
France must raise pension age to 64, prime minister says
Is This The End of Capitalism? (Ad)
Qatar replaces Russian company in Lebanon gas exploration
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
NASDAQ:IMVT

Immunovant - IMVT SEC Filings & 10K Form

$17.72
+0.12 (+0.68%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.38
$18.00
50-Day Range
$12.70
$19.72
52-Week Range
$3.14
$20.24
Volume
448,772 shs
Average Volume
1.29 million shs
Market Capitalization
$2.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.86

Recent Immunovant SEC Filings

DateFilerForm TypeView
01/27/2023
6:20 AM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2023
7:13 AM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2023
7:16 AM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2023
7:19 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2023
7:21 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2023
7:38 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2022
6:06 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2022
6:21 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2022
6:15 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2022
6:43 AM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2022
7:57 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2022
7:59 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2022
3:20 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2022
3:32 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
4:28 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2022
4:06 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2022
4:09 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2022
3:21 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2022
9:49 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2022
5:39 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2022
6:33 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2022
6:36 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:52 PM
Barnett Eva Renee (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:54 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:56 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:57 PM
Immunovant (Issuer)
Levine Mark S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
4:01 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2022
3:44 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:46 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:48 PM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:50 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:39 PM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2022
3:41 PM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2022
6:17 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2022
6:07 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2022
6:36 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2022
6:38 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2022
6:35 AM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
6:04 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
6:05 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2022
6:05 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2022
6:09 AM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/25/2022
3:23 PM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2022
3:26 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
6:05 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2022
6:08 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2022
3:34 PM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
6:18 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
6:16 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
6:23 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2021
3:02 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
5:14 PM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2021
4:29 PM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
5:56 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
6:09 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2021
8:46 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
7:09 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2021
7:56 AM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
8:50 AM
Immunovant (Issuer)
Macias William L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2021
6:36 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
6:40 AM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/23/2021
7:50 AM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:52 AM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:53 AM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:54 AM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:58 AM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:41 AM
Immunovant (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:43 AM
Elliott Michael James (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:45 AM
Immunovant (Issuer)
Yanchik Connealy Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:46 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
7:39 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
7:24 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/16/2021
7:24 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2021
5:52 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:39 PM
Immunovant (Issuer)
Jain Rita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
8:03 AM
Immunovant (Issuer)
Jain Rita (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2021
7:33 AM
Immunovant (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/12/2020
7:28 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
7:30 AM
Immunovant (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/18/2020
3:33 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:13 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
4:09 PM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
4:29 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
4:03 PM
Elliott Michael James (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
5:16 AM
Immunovant (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/25/2020
8:07 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2020
7:22 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2020
3:18 PM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2020
7:30 AM
Immunovant (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/29/2020
7:21 AM
Immunovant (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
7:47 AM
Immunovant (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:52 AM
Immunovant (Issuer)
MIGAUSKY GEORGE V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:31 AM
Immunovant (Issuer)
Yanchik Connealy Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:37 AM
Immunovant (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:40 AM
Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:42 AM
Hughes Douglas J. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:22 AM
Butchko Julia G. (Reporting)
Immunovant (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:26 AM
Immunovant (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:28 AM
Immunovant (Issuer)
MIDDLEKAUFF W BRADFORD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
6:25 PM
Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:IMVT) was last updated on 1/29/2023 by MarketBeat.com Staff